By Exec Edge Editorial Staff Santa Monica-based medical apparel maker FIGS, Inc. (NYSE: FIGS) posted a 9% rise in first-quarter revenue, leading its shares to surge 6% in after-hours trade Thursday. “Our first quarter performance was better than expected and...

  By Exec Edge Editorial Staff Potbelly Corp. (NASDAQ: PBPB) reported comparable sales for the first quarter of +22.2% vs. +24.4% year over year. The sandwich chain has opened 30 new shop agreements this year, signaling momentum in its Franchise...

By Exec Edge Editorial Staff Chicago-style fast-casual chain Portillo’s (Nasdaq: PTLO) said revenue rose 16%  to $156.1 million in the first quarter. Portillo’s will open nine new restaurants in 2023, with an emphasis on the Sun Belt, it said. The chain opened...

By Exec Edge Editorial Staff Solo Brands, Inc. (NYSE: DTC) shares rose 2% in premarket trading Thursday after the lifestyle outdoor products company posted a rise in revenue reaffirmed its full-year guidance. The company said net sales increased 7.3% to...

  By Healthcare Edge Editorial Staff Eterna Therapeutics Inc. (Nasdaq: ERNA) said it has acquired Exacis Biotherapeutics’ global immuno-oncology platform, which includes their pipeline of engineered cell therapy programs for hematologic and solid tumors. The acquisition gives Eterna an exclusive global license...

By Exec Edge Editorial Staff First Watch Restaurant Group, Inc. (Nasdaq: FWRG) shares rose 3 percent after the company raised guidance for 2023. The daytime dining chain raised its 2023 adjusted EBITDA guidance, projecting total revenue growth of 16% to...

  By Healthcare Edge Editorial Staff Biopharma company Ocean Biomedical (NASDAQ: OCEA) reported positive findings published in peer-reviewed journal Cancer Research, bolstering evidence of the potential impact of its anti-Chi3L1 antibody in suppressing severe glioblastoma tumor growth. “This is a...

IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange with senior management from Thirty Madison . The in-person interview featured President Michelle Carnahan and CFO Quan Zhang joined by IPO Edge Editor-in-Chief John Jannarone...

Healthcare Edge sister platform IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange with Catherine Roggero-Lovisi, CEO of Modern Meadow. Ms. Roggero-Lovisi spoke with IPO Edge Editor-in-Chief John Jannarone about her prior role at L’Oréal S.A., the advantages of a...

By Exec Edge Editorial Staff SAB Biotherapeutics (Nasdaq: SABS) said it saw positive results from a Phase 3 clinical trial that assessed its Covid-19 drug, SAB-185, in non-hospitalized people who were at high-risk for severe outcomes. SAB-185 demonstrated benefit in...